Bellicum Pharmaceuticals, Inc. Gains 80.83%

Wed, Aug 23, 2023 at 07:04 PM
Bellicum Pharmaceuticals, Inc. Gains 80.83%

Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) shot up at $0.5, a gain of 80.8%. On Wed, Aug 23, 2023, BLCM:NASDAQ hit a New 2-Week High of $0.5. From Wed, Aug 09, 2023, the stock recorded 20.00% Up Days and 36.36% Green Days

The stock spiked on Mon, May 08, 2023 at $1.31 with a volume of 100M+.

About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)

Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.